Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy
Author:
Funder
Universidad Industrial de Santander
Publisher
Elsevier BV
Subject
Pharmacology
Reference183 articles.
1. Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions;Adiwidjaja;Expert Opin. Drug Metabol. Toxicol.,2017
2. Curcumin ameliorates functional and structural abnormalities in cisplatin-induced neuropathy;Agthong;Exp. Neurobiol.,2015
3. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism;Ai;Cancer Lett.,2016
4. The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies;Al Moundhri;J. Med. Toxicol.,2013
5. Pharmacological targeting of cell cycle , apoptotic and cell adhesion signaling pathways implicated in chemoresistance of cancer cells;Alimbetov;Int. J. Mol. Sci.,2018
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Curcumin and Curcumin Derivatives for Therapeutic Applications: In vitro and In vivo Studies;Current Nutrition & Food Science;2024-12
2. Potential mechanisms of cancer prevention and treatment by sulforaphane, a natural small molecule compound of plant-derived;Molecular Medicine;2024-06-21
3. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review;Cancers;2024-01-05
4. EGFR/MAPK signaling pathway acts as a potential therapeutic target for sulforaphane-rescued heart tube malformation induced by various concentrations of PhIP exposure;Phytomedicine;2024-01
5. Daidzein nanosuspension in combination with cisplatin to enhance therapeutic efficacy against A549 non-small lung cancer cells: an in vitro evaluation;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3